🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety of Nevanac 0.1% compar...
Status
Completed
Location
Contact Alcon for Trial Locations
Start Date
2006-02
Trial ID
NCT00332774
The purpose of this study is to demonstrate superiority of Nepafenac Ophtha...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01853072
Treatments Being Tested
The purpose of this study was to assess the safety and efficacy of an inves...
Status
Completed
Location
Contact Alcon Call Center For Trial Locations
Start Date
2010-06
Trial ID
NCT01109173
The purpose of this study is to determine whether nepafenac is safe and eff...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00782717
The purpose of this study is to evaluate NEVANAC in patients with diabetic ...
Status
Terminated
Location
Contact Alcon Call Center For Trial Locations
Start Date
2009-08
Trial ID
NCT00939276
Treatments Being Tested
A randomized, multicenter, double masked, placebo controlled, parallel grou...
Status
Completed
Location
Key-Whitman Eye Center
Start Date
2018-03-28
Trial ID
NCT03499873
Treatments Being Tested
This study is being conducted to assess the effects of topical nonsteroidal...
Status
Completed
Location
Loma Linda University Health Care, Dept. of Ophthalmology
Start Date
2011-05
Trial ID
NCT01331005
Treatments Being Tested
The purpose of this study was to assess the safety and efficacy of Nepafena...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2011-03
Trial ID
NCT01318499
The purpose of this study is to demonstrate superiority of Nepafenac Ophtha...
Status
Completed
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01872611
Treatments Being Tested
To evaluate the safety and efficacy of Nepafenac 1 mg/ml Eye Drops, Suspens...
Status
Completed
Location
Bordeaux
Start Date
2005-11
Trial ID
NCT00405730